Comparison of ondansetron and ondansetron plus dexamethasone as antiemetic prophylaxis during cisplatin-containing chemotherapy
- 24 August 1991
- journal article
- clinical trial
- Published by Elsevier BV in The Lancet
- Vol. 338 (8765), 487-490
- https://doi.org/10.1016/0140-6736(91)90555-4
Abstract
No abstract availableThis publication has 22 references indexed in Scilit:
- Comparison of the 5-Hydroxytryptamine3(Serotonin) Antagonist Ondansetron (Gr 38032F) with High-Dose Metoclopramide in the Control of Cisplatin-Induced EmesisNew England Journal of Medicine, 1990
- Efficacy of Ondansetron (Gr 38032F) and the Role of Serotonin in Cisplatin-Induced Nausea and VomitingNew England Journal of Medicine, 1990
- Antiemetic control and prevention of side effects of anti-cancer therapy with lorazepam or diphenhydramine when used in combination with metoclopramide plus dexamethasone. A double-blind, randomized trialCancer, 1987
- 5-hydroxytryptamine m-receptor antagonism to prevent cisplatin-induced emesisNeuropharmacology, 1986
- Current Optimum Management of Anaplastic Germ Cell Tumours of the Testis and Other SitesBritish Journal of Urology, 1986
- Dexamethasone and high dose metoclopramide: efficacy in controlling cisplatin induced nausea and vomiting.BMJ, 1984
- On the receiving end—patient perception of the side-effects of cancer chemotherapyEuropean Journal of Cancer and Clinical Oncology, 1983
- Intravenous metoclopramide. An effective antiemetic in cancer chemotherapyJAMA, 1982
- Antiemetic Efficacy of High-Dose Metoclopramide: Randomized Trials with Placebo and Prochlorperazine in Patients with Chemotherapy-Induced Nausea and VomitingNew England Journal of Medicine, 1981
- The Comparison of Success Rates in Cross-Over Trials in the Presence of an Order EffectJournal of the Royal Statistical Society Series C: Applied Statistics, 1981